| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 751008 | 60314 | CORDIPLAST 10 mg/24 h PARCHES TRANSDERMICOS | CORDIPLAST 10 mg/24 h PARCHES TRANSDERMICOS , 30 parches | 10 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60314/60314_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60314/60314_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 41928 | NORGINE DE ESPANA S.L.U. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2003-02-14 | 0 | 2011-05-04 | 692459 | View Edit Delete | |||||||||||
| 653817 | 60318 | SANDIMMUN NEORAL 50 mg CAPSULAS BLANDAS | SANDIMMUN NEORAL 50 mg CAPSULAS BLANDAS, 30 cápsulas | 50 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60318/60318_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60318/60318_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2012-03-27 | 1 | 2013-01-03 | 662171, 692376, 650093 | View Edit Delete | |||||||||||
| 653809 | 60319 | SANDIMMUN NEORAL 25 mg CAPSULAS BLANDAS | SANDIMMUN NEORAL 25 mg CAPSULAS BLANDAS, 30 cápsulas | 25 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60319/60319_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60319/60319_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2012-03-27 | 1 | 2013-01-03 | 650092, 692368, 662163 | View Edit Delete | |||||||||||
| 653825 | 60320 | SANDIMMUN NEORAL 100 mg CAPSULAS BLANDAS | SANDIMMUN NEORAL 100 mg CAPSULAS BLANDAS , 30 cápsulas | 100 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60320/60320_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60320/60320_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2012-03-27 | 1 | 2013-01-03 | 662189, 650094, 692350 | View Edit Delete | |||||||||||
| 645705 | 60324 | BICARBONATO SODICO 1M GRIFOLS SOLUCION INYECTABLE | BICARBONATO SODICO 1M GRIFOLS SOLUCION INYECTABLE , 100 ampollas de 10 ml | 8,4% (1 M) | 1 | 1 | 1 | 100 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60324/60324_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60324/60324_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1234 | LABORATORIOS GRIFOLS S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2006-11-01 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 692285 | 60326 | PULMOZYME 2.500 U/2,5 ml SOLUCIÓN PARA INHALACIÓN POR NEBULIZADOR | PULMOZYME 2.500 U/2,5 ml SOLUCIÓN PARA INHALACIÓN POR NEBULIZADOR, 30 ampollas | 2.500 U | 1 | 30 | 40 | 30 ampollas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60326/60326_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60326/60326_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24369 | ROCHE FARMA S.A. | 1994-05-01 | 1 | 1 | 1 | 1994-05-01 | 1994-05-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 692160 | 60334 | EVOPAD 50 microgramos/24 H PARCHES TRANSDERMICOS | EVOPAD 50 microgramos/24 H PARCHES TRANSDERMICOS, 8 parches | 50 microgramos/24 h | 35 | 8 | 28 | 8 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60334/60334_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60334/60334_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 29320 | THERAMEX HEALTHCARE SPAIN S.L. | 1994-06-01 | 1 | 1 | 1 | 1994-06-01 | 1994-06-01 | 0 | 2020-04-07 | View Edit Delete | ||||||||||||
| 692145 | 60335 | RISPERDAL 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | RISPERDAL 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 3 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60335/60335_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60335/60335_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1994-05-01 | 1 | 1 | 1 | 1994-05-01 | 1994-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 692152 | 60335 | RISPERDAL 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | RISPERDAL 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 20 comprimidos | 3 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60335/60335_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60335/60335_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1994-05-01 | 1 | 1 | 1 | 1994-05-01 | 1994-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 692129 | 60336 | RISPERDAL 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | RISPERDAL 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 1 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60336/60336_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60336/60336_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1994-05-01 | 1 | 1 | 1 | 1994-05-01 | 1994-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 692079 | 60342 | GARYDOL 5mg/2mg COMPRIMIDOS PARA CHUPAR | GARYDOL 5mg/2mg COMPRIMIDOS PARA CHUPAR , 20 comprimidos | 5 mg/2 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60342/60342_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60342/60342_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 1994-04-01 | 1 | 1 | 1 | 2023-01-13 | 2023-01-13 | 1 | 2023-01-16 | View Edit Delete | ||||||||||||
| 671149 | 60350 | DEPAKINE CRONO 500 mg COMPRIMIDOS DE LIBERACION PROLONGADA | DEPAKINE CRONO 500 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 100 comprimidos | 500 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/60350/60350_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60350/60350_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 40842 | SANOFI AVENTIS S.A. | 1995-11-01 | 1 | 1 | 1 | 1995-11-01 | 1997-07-01 | 0 | 2011-06-09 | 691865 | View Edit Delete | |||||||||||
| 671131 | 60351 | DEPAKINE CRONO 300 mg COMPRIMIDOS DE LIBERACION PROLONGADA | DEPAKINE CRONO 300 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 100 comprimidos | 300 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/60351/60351_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60351/60351_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 40842 | SANOFI AVENTIS S.A. | 1995-11-01 | 1 | 1 | 1 | 1995-11-01 | 1997-07-01 | 0 | 2011-06-09 | 691857 | View Edit Delete | |||||||||||
| 691840 | 60352 | DEPAKINE 100 mg/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | DEPAKINE 100 mg/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 ampolla de disolvente | 400 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/60352/60352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60352/60352_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40842 | SANOFI AVENTIS S.A. | 1995-11-01 | 1 | 1 | 1 | 1995-11-01 | 1995-11-01 | 0 | 2011-06-09 | View Edit Delete | ||||||||||||
| 607142 | 60353 | CLORURO DE POTASIO BRAUN 1 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | CLORURO DE POTASIO BRAUN 1 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 x 10 ml (MP Connect) | 1 mEq/ml inyectable 10 ml | 1 | 20 | 1 | 20 x 10 ml (MP Connect) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60353/60353_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60353/60353_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2019-02-04 | 0 | 2019-07-04 | View Edit Delete | ||||||||||||
| 607145 | 60354 | CLORURO DE POTASIO BRAUN 2 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | CLORURO DE POTASIO BRAUN 2 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 x 5 ml (MP Connect) | 2 mEq/ml inyectable 5 ml | 1 | 20 | 1 | 20 x 5 ml (MP Connect) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60354/60354_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60354/60354_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2019-02-06 | 0 | 2019-07-04 | View Edit Delete | ||||||||||||
| 607146 | 60354 | CLORURO DE POTASIO BRAUN 2 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | CLORURO DE POTASIO BRAUN 2 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 x 10 ml (MP Connect) | 2 mEq/ml inyectable 10 ml | 1 | 20 | 1 | 20 x 10 ml (MP Connect) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60354/60354_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60354/60354_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2019-02-06 | 0 | 2019-07-04 | View Edit Delete | ||||||||||||
| 607147 | 60354 | CLORURO DE POTASIO BRAUN 2 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | CLORURO DE POTASIO BRAUN 2 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 x 20 ml (MP Connect) | 2 mEq/ml inyectable 20 ml | 1 | 20 | 1 | 20 x 20 ml (MP Connect) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60354/60354_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60354/60354_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2019-02-06 | 0 | 2019-07-04 | View Edit Delete | ||||||||||||
| 691774 | 60356 | FORMULAEXPEC 13,33 mg/ml JARABE SABOR MIEL | FORMULAEXPEC 13,33 mg/ml JARABE SABOR MIEL, 1 frasco de 180 ml | 13,3 mg/ml | 6 | 180 | 26 | 1 frasco de 180 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60356/60356_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60356/60356_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8994 | PROCTER & GAMBLE ESPANA S.A. | 1994-05-01 | 1 | 1 | 1 | 2024-05-23 | 2024-05-23 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 691758 | 60357 | FORMULATUS 1,33 mg/ml JARABE SABOR MIEL | FORMULATUS 1,33 mg/ml JARABE SABOR MIEL, 1 frasco de 180 ml | 1,33 mg/ml | 6 | 180 | 26 | 1 frasco de 180 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60357/60357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60357/60357_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8994 | PROCTER & GAMBLE ESPANA S.A. | 1994-05-01 | 1 | 1 | 1 | 2024-05-23 | 2024-05-23 | 1 | 2024-07-09 | View Edit Delete |
Page 263 of 1036, showing 20 records out of 20702 total, starting on record 5241, ending on 5260